Imaging biomarkers in Parkinson’s disease and movement disorders: emerging insights from multimodal neuroimaging
Authors:
- E. Mark HaackeEHE. Mark Haacke
- Sagar BuchSBSagar Buch
- Naying HeNHNaying He
- Stephane LehericySLStephane Lehericy
- David VaillancourtDVDavid Vaillancourt
- Sven HallerSHSven Haller
- Yongsheng ChenYCYongsheng Chen
- Peter LeWittPLPeter LeWitt
Open Access
- 13 August 2026
- journal article
- Published by Elsevier in NeuroImage
- Vol. 339
Abstract
No abstract availableThis publication has 70 references indexed in Scilit:
- Automated Imaging Differentiation for ParkinsonismJAMA Neurology, 2025
- Contribution of MRI for the Early Diagnosis of Parkinsonism in Patients with Diagnostic UncertaintyMovement Disorders, 2024
- Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson DiseaseJAMA Neurology, 2021
- Oxidative stress and regulated cell death in Parkinson’s diseaseAgeing Research Reviews, 2021
- Longitudinal Changes in Neuromelanin MRI Signal in Parkinson's Disease: A Progression MarkerMovement Disorders, 2021
- Resting‐state Functional MRI in Parkinsonian SyndromesMovement Disorders Clinical Practice, 2019
- Movement disorder society criteria for clinically established early Parkinson's diseaseMovement Disorders, 2018
- Biomarkers for Parkinson’s Disease: Recent AdvancementNeuroscience Bulletin, 2017
- Free water elimination and mapping from diffusion MRIMagnetic Resonance in Medicine, 2009
- A Global Estimator Unbiased by Local ChangesNeuroImage, 2001